newsfilter
← Latest News
GlobeNewswire·

Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology

AMIX
  • Autonomix Medical, Inc. received U.S. Patent No. 12,793,841 on Nov. 10, 2026, covering medical devices with circuitry for capturing & processing physiological signals.
  • The patented technology enables signal acquisition & processing near the biological source to support high-resolution sensing, efficient data transmission, & real-time monitoring.
  • The architecture incorporates distributed processing modules, configurable sensing capabilities, & efficient data transmission designed for high-density signal acquisition within catheter-based devices.
  • Potential clinical applications include cardiovascular interventions, electrophysiology, pain management, & other procedures requiring precise physiological monitoring.
  • The patent strengthens Autonomix's intellectual property portfolio supporting its proprietary catheter-based sensing technology & first-in-class microchip sensing array.
  • The technology aims to enable transvascular diagnosis & treatment of peripheral nervous system diseases across indications such as cardiology, hypertension, & chronic pain.
  • Autonomix's technology remains investigational & has not yet been cleared for marketing in the United States.
Company
Autonomix Medical, Inc.
Keywords
Nasdaq:AMIX, Autonomix Medical, Inc., Autonomix Medical, Inc., New U.S. Patent, NASDAQ: AMIX, medical device company, transvascular diagnosis, catheter-based microchip